Centro de Investigación Biomédica en Red sobre Enfermedades Raras -ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2023

  1. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy

    Cell Reports Medicine, Vol. 4, Núm. 12

  2. NOTCH1 mutation in chronic lymphocytic leukaemia is associated with an enhanced cell cycle G1/S transition and specific cyclin overexpression: Preclinical ground for targeted inhibition

    British Journal of Haematology, Vol. 201, Núm. 3, pp. 470-479

2022

  1. Persistent Large Granular Lymphocyte Clonal Expansions: “The Root of Many Evils”—And of Some Goodness

    Cancers, Vol. 14, Núm. 5

2021

  1. Minimal residual disease in multiple myeloma: Something old, something new

    Cancers, Vol. 13, Núm. 17

2020

  1. Cancer testis antigens in myelodysplastic syndromes revisited: a targeted RNA-seq approach

    OncoImmunology, Vol. 9, Núm. 1

2018

  1. An early increase of CD56 bright natural killer subset as dominant effect and predictor of response to extracorporeal photopheresis for graft-versus-host disease

    Transfusion, Vol. 58, Núm. 12, pp. 2924-2932